You are here

  • Home
  • Archive
  • Volume 69, Issue 10
  • Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma

Article metrics

Article menu
Download PDFPDF
PostScript
PostScript
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to August 2024

AbstractFullPdf
Dec 20197588050
Jan 20208178531
Feb 20204224326
Mar 20202202216
Apr 20201693312
May 20201312113
Jun 20201511310
Jul 2020104127
Aug 20204955
Sep 20204704631
Oct 20203465133
Nov 20202542518
Dec 20202363419
Jan 20211872312
Feb 20211752722
Mar 2021120159
Apr 20212962213
May 202152124
Jun 2021312513
Jul 202131165
Aug 2021362211
Sep 202140209
Oct 2021159188
Nov 2021148196
Dec 2021152228
Jan 2022193238
Feb 2022163103
Mar 2022167152
Apr 2022176166
May 2022130154
Jun 2022116123
Jul 2022120226
Aug 202210991
Sep 2022155144
Oct 2022114121
Nov 20228743
Dec 20227252
Jan 202350143
Feb 202311890
Mar 2023138145
Apr 20237821
May 20235370
Jun 20236375
Jul 20238152
Aug 20235731
Sep 20239230
Oct 202312070
Nov 20239610
Dec 20236742
Jan 20249984
Feb 20243355
Mar 20245455
Apr 202412955
May 20247388
Jun 20246344
Jul 202413625
Aug 20244064
Total8796987493